· The company¿s turnover totalled 3.5 million euro in the first nine months of the year, 35% more than in the same period of last year
Granada / Madrid, 23 October 2003. PULEVA BIOTECH chalked up a net profit of 1.3 million euro in the first nine months of 2003, representing a year-on-year growth of 49%, while its turnover totalled 3.5 million euro, 35% more than that obtained at September 2002.
An international commercial plan was set underway during this quarter for the product CV-17. Meanwhile, installation began recently of the plant for producing GH-28. This family of products is to be launched in the second half of next year. The company has also started designing new production plants to manufacture the other products included in the PULEVA BIOTECH portfolio.